Study identifies two factors that may help patients benefit from off-the-shelf CAR T-cell therapies

Researchers astatine The University of Texas MD Anderson Cancer Center person traced however off-the-shelf chimeric antigen receptor (CAR) T cells behave successful patients, revealing however immune rejection and differences among CAR T cells power their quality to multiply aft infusion.